KLHL7

Across TCGA pan-cancer cohorts, KLHL7 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated KLHL7 data layer compared with 24 for mass-spec protein and 10 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher KLHL7 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated KLHL7 expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

CCRCC, LUAD, and HNSC are the cancer types where KLHL7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	III,IV	0.207	0.704	.036	5	view →
LUAD	OS	Tertile	II,III,IV	1.000	0.791	.030	2	view →
HNSC	DFS	Quartile	II,III,IV	0.983	0.846	.046	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

KLHL7–CCRCC (DFS)

Open the CCRCC breakdown →